Last reviewed · How we verify
Tretinoin Facial Gel
Tretinoin Facial Gel is a Small molecule drug developed by Bausch Health Americas, Inc.. It is currently FDA-approved. Also known as: Retin-A Micro Gel 0.04% Pump.
At a glance
| Generic name | Tretinoin Facial Gel |
|---|---|
| Also known as | Retin-A Micro Gel 0.04% Pump |
| Sponsor | Bausch Health Americas, Inc. |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne Vulgaris (PHASE1)
- Comparison of Efficacy of Metformin Gel 30% vs Triple Combination Cream (Hydroquinone 4%, Flucinolone Acetonide 0.01%, Tretinoin 0.025%) in Treatment of Melasma in Tertiary Care Hospital Karachi (NA)
- Split-face Tolerability Comparison Between Adapalene-Benzoyl Peroxide Gel Versus Tretinoin Gel (PHASE4)
- A Study Comparing Tretinoin Gel Microsphere, 0.1% and RETIN-A MICRO ® Gel Microsphere, 0.1% in the Treatment of Acne Vulgaris (EARLY_PHASE1)
- Comedone Extraction and Oral Doxycycline In The First Line Treatment of Moderate Acne Vulgaris (PHASE1)
- Pilot Study of Tolerability and Effectivity of Two Combination Topical Acne Products (PHASE4)
- Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Facial Acne (PHASE4)
- A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tretinoin Facial Gel CI brief — competitive landscape report
- Tretinoin Facial Gel updates RSS · CI watch RSS
- Bausch Health Americas, Inc. portfolio CI
Frequently asked questions about Tretinoin Facial Gel
What is Tretinoin Facial Gel?
Tretinoin Facial Gel is a Small molecule drug developed by Bausch Health Americas, Inc..
Who makes Tretinoin Facial Gel?
Tretinoin Facial Gel is developed and marketed by Bausch Health Americas, Inc. (see full Bausch Health Americas, Inc. pipeline at /company/bausch-health-americas-inc).
Is Tretinoin Facial Gel also known as anything else?
Tretinoin Facial Gel is also known as Retin-A Micro Gel 0.04% Pump.
What development phase is Tretinoin Facial Gel in?
Tretinoin Facial Gel is FDA-approved (marketed).
Related
- Manufacturer: Bausch Health Americas, Inc. — full pipeline
- Also known as: Retin-A Micro Gel 0.04% Pump
- Compare: Tretinoin Facial Gel vs similar drugs
- Pricing: Tretinoin Facial Gel cost, discount & access